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Edited by Gerrit van MeerAbstract We investigated the interaction between apolipopro-
tein E (apoE) and ceramide (CER)-enriched domains on the
particles, by using lipid emulsions containing sphingomyelin
(SM) or CER as model particles of lipoproteins. The sphingo-
myelinase (SMase)-induced aggregation of emulsion particles
was prevented by apoE. CER increased the amount of apoE
bound to emulsion particles. The confocal images of CER-con-
taining large emulsions with two ﬂuorescent probes showed
three-dimensional microdomains enriched in CER. SMase also
induced the formation of CER-enriched domains. We propose
apoE prefers to bind on CER-enriched domains exposed on
particle surface, and thus inhibits the aggregation or fusion
of the particles.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The subendothelial retention of atherogenic lipoproteins,
low density lipoproteins (LDL) and triglyceride-rich lipopro-
teins is a critical step in atherogenesis, and lipoproteins ex-
tracted from atherosclerotic lesions are aggregated or
prone to aggregate. Human plasma sphingomyelin (SM) lev-
els have been reported to be a risk factor for coronary ar-
tery disease [1]. The liver synthesizes sphingolipids de novo
and incorporates the newly synthesized sphingolipids into
very low density lipoproteins (VLDL) [2]. SM becomes en-
riched in VLDL remnants, and the SM/phosphatidylcholine
(PC) ratio in LDL is quite high (0.5) [3]. LDL extracted
from human atherosclerotic lesions is highly enriched in
SM compared with plasma LDL [3]. A variety of cell typesAbbreviations: LDL, low density lipoprotein; SM, sphingomyelin;
VLDL, very low density lipoprotein; PC, phosphatidylcholine; SMase,
sphingomyelinase; CER, ceramide; apoE, apolipoprotein E; LRP,
LDL receptor-related protein; HSPG, heparan sulfate proteoglycans;




nine perchlorate; DLS, dynamic light scattering; PL, phospholipid
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endothelial cells, secrete sphingomyelinase (SMase) [4]. The
ceramide (CER) content of aggregated LDL in atheroscle-
rotic lesions is 10–50-fold higher than that of plasma LDL
[5]. SM in LDL is converted to CER by arterial wall SMase
and this process may contribute to subendotherial LDL
aggregation. Treatment of LDL particles with bacterial
SMase has been shown to induce both aggregation and fu-
sion of the particles through the accumulation of CER with-
in the LDL particles [5–7]. LDL isolated from human
plasma has been reported to possess SMase activity [8]. In
LDL aggregates, the SMase of LDL would be able to cata-
lyze the formation of CER in the contacting, adjacent lipo-
proteins [9]. Furthermore, these LDL aggregates potently
induce macrophage foam cell formation [6,10]. The genera-
tion of CER by arterial wall SMase could thus be involved
in atherogenesis.
Apolipoprotein E (apoE), a 299-residue plasma apolipo-
protein, is a ligand for LDL receptor, LDL receptor-related
protein (LRP) and VLDL receptor, and binds to cell surface
heparan sulfate proteoglycans (HSPG). ApoE promotes the
internalization of lipoproteins and lipid emulsions by cells
[11,12]. Within atherosclerotic lesions, lipoproteins have been
found to contain apoE in addition to apolipoprotein B [13].
The liver produces the vast majority of plasma apoE, but
apoE is also synthesized by macrophages in various organs
[14]. Fazio et al. [15] demonstrated that the majority of
apoE in the lesion is synthesized locally by lesion macro-
phages and that local apoE expression by macrophages
was atheroprotective. However, the role of macrophage-se-
creted apoE is still uncertain.
Emulsion particles have been used as models for plasma
lipoproteins. Our previous studies showed that the genera-
tion of CER in emulsions by SMase facilitated HSPG and
LRP-mediated uptake by J774 macrophages, and that apoE
further increased the uptake of CER-containing emulsions
compared with SM-containing emulsions [12]. In the present
study, we have shown that the SMase-induced aggregation
of emulsion particles was prevented by apoE, and that
CER in emulsion particles increased the binding of apoE.
By using confocal ﬂuorescence microscopy, we have
produced images that demonstrate the existence of three-
dimensional microdomains in CER-containing particles.
Our results support a role for CER-enriched domains
formed by SMase in the subendothelial retention of lipopro-
teins, which lead to lipoprotein aggregation and lesion
initiation.ation of European Biochemical Societies.
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2.1. Materials
Egg yolk PC was generously provided by Asahi Kasei Co. Triolein
(TO), egg yolk SM, and SMase (from Bacillus cereus) were purchased
from Sigma Chemical Co. Egg CER was obtained from Avanti Polar
Lipids. 2-(4,4-Diﬂuoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-
3-pentanoyl)-1-hexadecanoyl-sn-glycero-3-phosphocholine (BODIPY-
PC) and 1,1 0-dioctadecyl-3,3,3 0,3 0-tetramethylindocarbocyanine
perchlorate (DiI-C18) were obtained from Molecular Probes. All other
chemicals used were of the highest reagent grade.
2.2. Preparation of emulsions
The lipid emulsions were prepared by the method described previ-
ously using a high pressure emulsiﬁer (Nanomizer System YSNM-
2000AR; Yoshida Kikai Co.) [12]. Brieﬂy, mixtures of TO, PC,
SM and CER were suspended in HEPES buﬀer (137 mM NaCl,
6 mM KCl, 6.1 mM D-glucose and 10 mM HEPES; pH 7.4) and
successively emulsiﬁed under 100 MPa of pressure at 40–60 C. After
the removal of contaminating vesicles by ultracentrifugation
(55 000 · g, 60 min), homogenous emulsion particles were obtained.
The mean particle diameter of each emulsions was about 120 nm,
determined from dynamic light scattering (DLS) measurements using
Photal LPA-3000/3100 (Otsuka Electronic Co.). The concentrations
of phospholipid (PL) and TO were determined using enzymatic as-
say kits purchased from Wako Pure Chemicals. The molar ratios
of core TO to total surface PL for isolated TO-PC, TO-PC/SM
(2/1), and TO-PC/CER (2/1) emulsions were 4.95, 5.20, and 4.19,
respectively.
2.3. Preparation of large emulsions
Mixtures of TO, PC, SM and CER were suspended in HEPES buﬀer
and successively emulsiﬁed under 40 MPa of pressure at 40–60 C
using a high pressure emulsiﬁer. For confocal microscopy visualiza-
tion, BODIPY-PC and DiI-C18 were added into the lipid mixtures at
a ratio of 0.5 mol% of PC, SM and CER. The contaminating vesicles
were removed by ultracentrifugation (55 000 · g, 60 min). The mean
particle diameter of each large emulsions was about 400 nm measured
by DLS. The molar ratios of core TO to total surface PL for isolated
large TO-PC, TO-PC/SM (2/1), TO-PC/CER (2/1) emulsions were
11.8, 12.5 and 16.8, respectively.
2.4. Size estimation of the emulsion particles aggregated by SMase
Recombinant human apoE (isoform E3) was provided by Pepro
Tech EC Ltd. To minimize self-association, the recombinant apoE
was added to 6 M guanidine hydrochloride solution and dialyzed
extensively against HEPES buﬀer. TO-PC/SM (2/1) emulsions
(250 lM TO) were preincubated with 10 lg/ml apoE at 37 C for
30 min. TO-PC/SM (2/1) emulsions were then incubated with 10 mU/
ml SMase at 37 C in HEPES buﬀer (pH 7.4) containing 0.6 mM
MgCl2 and 1.1 mM CaCl2. After incubation for the indicated periods,
the hydrolysis was stopped by the addition of EDTA to give a ﬁnal
concentration of 10 mM. The degree of aggregation was determined
as the mean diameter of emulsion particles measured by DLS. The
mean hydrodynamic diameter was evaluated by the cumulant method.
Assays for SM hydrolysis were performed in the absence or presence of
10 lg/ml apoE according to the previously described method [12]. The
SMase preparation did not contain detectable phospholipase C activity
against PC, because released phosphorylcholine was not detected after
the incubation of TO-PC emulsions with 10 mU/ml SMase for 2 h at
37 C.Fig. 1. Eﬀects of apoE on the aggregation of emulsion particles
induced by SMase. TO-PC/SM (2/1) emulsions (250 lM TO) were
incubated with 10 mU/ml SMase at 37 C in the absence (open circles)
or presence (closed circles) of 10 lg/ml apoE. TO-PC/SM (2/1)
emulsions (250 lM TO) were incubated at 37 C in the presence of
10 lg/ml apoE without SMase (closed triangles). At the indicated time
points, SM hydrolysis was stopped with EDTA, and the degree of
aggregation was determined as the mean diameter of emulsion particles
by DLS measurements.2.5. ApoE binding assay
Lipid emulsions (250 lM TO) were incubated with 10 lg/ml apoE at
37 C for 30 min, which allows suﬃcient time for equilibrium binding
[16]. The mixtures were subjected to ultracentrifugation (55 000 · g,
30 min) to separate both emulsions and lipid-bound apoE from free
apoE. The free apoE concentration was determined by measuring
the peak area of tryptophan ﬂuorescence near 335 nm (excited at
280 nm) with a Hitachi F-4500 spectroﬂuorometer. The lipid-bound
apoE amount was calculated by subtracting the background of free
apoE concentration in the top fraction obtained from the results of
centrifugation of lipid-free apoE solution [16].2.6. Confocal ﬂuorescence microscopy
BODIPY-PC- and DiI-C18-labeled large emulsions were placed on a
glass slide, and enclosed by a cover glass. For experiments with SMase,
large emulsions (500 lM TO) were preincubated with 10 mU/ml
SMase at 37 C for 1 h in HEPES buﬀer (pH 7.4) containing
0.6 mM MgCl2 and 1.1 mM CaCl2, and then EDTA was added. Con-
focal ﬂuorescence images were taken with a confocal microscope
(MRC-1024; BioRad) at 488 and 568 nm excitation, and emission ﬁl-
ters of 522DF35 for BODIPY-PC and HQ598DF40 for DiI-C18. The
objective was 60· oil immersion, numerical aperture 1.40. Image acqui-
sition was carried out at room temperature, 25 C.3. Results
3.1. Aggregation of emulsion particles induced by SMase and
apoE binding to emulsions
We have previously shown that SM-containing emulsions
became aggregated by SMase following a rapid enzymatic ac-
tion [12]. To examine the eﬀect of apoE on the SMase-induced
aggregation of emulsion particles, we treated TO-PC/SM (mo-
lar ratio 2/1) emulsions (250 lM TO) with 10 mU/ml SMase in
the absence or presence of 10 lg/ml apoE for various periods
(Fig. 1). The aggregation of the emulsion particles was deter-
mined from the mean diameter of emulsion particles measured
by DLS. Upon incubation with SMase, the mean diameter of
emulsion particles increased with time. The addition of apoE
arrested the SMase-induce aggregation of particles. ApoE
alone had no eﬀect on the size of TO-PC/SM (2/1) emulsions.
Within the ﬁrst 5 min of exposure to 10 mU/ml SMase, almost
all of the SM molecules in TO-PC/SM (2/1) emulsions were
hydrolyzed in the absence and presence of 10 lg/ml apoE (data
not shown). These results suggest apoE bound on emulsion
surface inhibits the interactions between particles that cause
aggregation, but does not aﬀect the SMase enzymatic activity.
To investigate the eﬀect of CER on apoE binding to the par-
ticles, we compared the amount of apoE bound to TO-PC,
TO-PC/SM (2/1), and TO-PC/CER (2/1) emulsions (Fig. 2).
As previously reported [11], the incorporation of SM into
the emulsion surface markedly reduced the binding amount
of apoE. The amount of apoE bound to TO-PC/CER (2/1)
Fig. 2. Eﬀects of SM and CER on the binding of apoE to emulsion
particles. TO-PC (open bar), TO-PC/SM (2/1) (cross-hatched bar), and
TO-PC/CER (2/1) (ﬁlled bar) emulsions (250 lM TO) were incubated
with 10 lg/ml apoE for 30 min at 37 C. The mean particle diameter of
each emulsions was about 120 nm. Each bar represents the mean
±S.D. of three measurements. Multiple comparisons were performed
using the Bonferroni test following a one-way analysis of variance.
\P < 0.05, signiﬁcantly diﬀerent from TO-PC emulsions. §P < 0.05,
signiﬁcantly diﬀerent from TO-PC/SM (2/1) emulsions.
Fig. 3. Confocal ﬂuorescence microscopy of emulsion particles. TO-
PC (A), TO-PC/SM (2/1) (B), and TO-PC/CER (2/1) (C) emulsions
contained BODIPY-PC (green) and DiI-C18 (red) dyes. The bar
represents 5 lm.
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or TO-PC/SM (2/1) emulsions, indicating the conversion of
SM to CER at the emulsion surface enhances the binding of
apoE.
3.2. Confocal microscopic images of large emulsions
The formation of CER-enriched domains has been demon-
strated by ﬂuorescence microscopy of the dim-
yristoylphosphatidylcholine/CER monolayer [17]. In this
study, we conﬁrmed the existence of CER-enriched domains
in emulsion particles by confocal ﬂuorescence microscopy.
Two ﬂuorescent lipid analogs distinguished the ﬂuid and or-
dered membrane phases. The partition of DiI-C18 favors the
ordered membrane phases, whereas BODIPY-PC having a
bulky moiety on an acyl chain is expected to favor the ﬂuid
phase [18–20]. Figs. 3 and 4 show the confocal microscopic
images of TO-PC, TO-PC/SM (2/1) and TO-PC/CER (2/1)
large emulsions containing both BODIPY-PC and DiI-C18.
BODIPY-PC was localized mainly in emulsion surface mono-
layer, while DiI-C18 was partitioned into emulsion surface and
TO core. In TO-PC large emulsions, the uniform distributions
of BODIPY-PC in emulsion surface and DiI-C18 in emulsion
surface and core were demonstrated (Figs. 3A and 4A). SM
in emulsion surface had no eﬀect on the distribution of BOD-
IPY-PC and DiI-C18 in the particles (Figs. 3B and 4B). In the
presence of CER, however, we could observe partial segrega-
tion of the two dyes in 88% of the particles. Figs. 3C and
4C–G show that DiI-C18 ﬂuorescence was non-uniform in
TO-PC/CER (2/1) emulsions. For the same emulsion particle,
BODIPY-PC ﬂuorescence at the surface was also non-uniform
with bright and dark regions complementary to those of DiI-
C18. DiI-C18 ﬂuorescence identiﬁes the CER-rich ordered
phase, whereas BODIPY-PC ﬂuorescence identiﬁes the PC-
rich ﬂuid phase. These ﬁndings indicate the CER enrichment
in emulsion particles results in the formation of three-dimen-
sional microdomains extending from emulsion core to surface.These CER-enriched domains present a variety of
morphologies.
In order to investigate the eﬀect of SMase on the phase sep-
aration in emulsion particles, we observed TO-PC/SM (2/1)
large emulsions after incubation with SMase. In Fig. 5, SMase
induced the clustering of DiI-C18 and the separation of
BODIPY-PC from DiI-C18 at the particle surface. Thus, the
generation of CER by SMase is followed by the formation
of three-dimensional microdomains enriched in CER. The size
of untreated TO-PC/SM (2/1) large emulsions was less than
Fig. 4. Phase separation in emulsion particles visualized using confo-
cal ﬂuorescence microscopy. TO-PC (A), TO-PC/SM (2/1) (B), and
TO-PC/CER (2/1) (C–G) emulsions contained BODIPY-PC (green)
and DiI-C18 (red) dyes. In each ﬁgure, BODIPY-PC ﬂuorescence is
shown on the left, DiI-C18 ﬂuorescence in the center, and a merged
image on the right. In TO-PC/CER (2/1) emulsions, DiI-C18 ﬂuores-
cence identiﬁes CER-enriched domains which present a variety of
morphologies (C–G). The bar represents 1 lm.
Fig. 5. Eﬀect of SMase on phase behavior in emulsion particles. TO-
PC/SM (2/1) emulsions (500 lM TO) containing BODIPY-PC (green)
and DiI-C18 (red) were incubated with 10 mU/ml SMase for 1 h at
37 C. After incubation, hydrolysis was stopped by the addition of
EDTA. In each ﬁgure, BODIPY-PC ﬂuorescence is shown on the left,
DiI-C18 ﬂuorescence in the center, and a merged image on the right.
DiI-C18 ﬂuorescence identiﬁes CER-enriched domains which present a
variety of morphologies (A–D). The bar represents 1 lm.
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sions was 4.6 lm (Fig. 5A). The emulsion particles after SMase
treatment became larger compared with untreated TO-PC/SM
(2/1) large emulsions, demonstrating SMase leads to the fusion
as well as the aggregation of emulsion particles.4. Discussion
CER consists of a fatty acid bound to the amino group of
sphingosine. In this study, we used egg SM and egg CER both
of which contain primarily palmitic acid. C16-CER has been
found to increase the order of the acyl chains in PC bilayers,and give rise to in-plane phase separation of CER-rich and
-poor domains [21,22]. Huang et al. [23] observed using 2H-
NMR spectroscopy that addition of CER induced lateral
phase separation of ﬂuid PL bilayers into regions of gel and
ﬂuid phases, CER partitioning largely into the gel phase of
deuterated dipalmitoylphosphatidylcholine. Microdomain for-
mation by CER has been demonstrated by diﬀerential scan-
ning calorimetry [24,25]. Holopainen et al. [21] detected
CER-enriched microdomains in ﬂuid PC bilayers using a pyr-
ene-labeled CER analog that is sensitive to lateral mobility and
local concentration of the ﬂuorophore in the membrane, and
showed that SMase led to the formation of CER-enriched do-
mains in bilayers composed of PC and SM. The rapid enzy-
matic formation of CER is followed by much slower
reorganization process, resulting in the formation of microdo-
mains enriched in CER [21]. Unlike PC, which can act only as
acceptors of hydrogen bonds due to the phosphate moiety, SM
and CER can act as both acceptors and donors through their
hydroxyl and amide groups. Microdomain formation arises
due to the properties of the CER headgroup, and the large
hydration of the phosphorylcholine group may cause strong
steric hindrance prohibiting hydrogen bonding in SM–SM
interactions [21].
Confocal ﬂuorescence microscopy has enabled the direct
observation and analysis of phase domains in giant unila-
mellar vesicles of dipalmitoylphosphatidylcholine/dila-
S. Morita et al. / FEBS Letters 579 (2005) 1759–1764 1763uroylphosphatidylcholine/cholesterol [18,19]. In our report,
TO-PC, TO-PC/SM, and TO-PC/CER large emulsions were
imaged by confocal ﬂuorescence microscopy with two ﬂuo-
rescent probes, DiI-C18 and BODIPY-PC (Figs. 3 and 4).
Phase separation was visualized by diﬀerential probe parti-
tion into the coexistent phases. In TO-PC and TO-PC/SM
large emulsions, two phases were identiﬁed, TO-rich hydro-
phobic core and surface monolayer. Thus, SM at emulsion
surface may have no inﬂuence on the phase behavior. The
confocal images of TO-PC/CER large emulsions reveal the
morphology of CER-enriched domains in emulsion particles.
CER molecules were shown to form three-dimensional
microdomains extending from the inner core to surface of
the emulsion particles. The generation of CER by SMase
also induced the formation of three-dimensional microdo-
mains (Fig. 5). These ﬁndings suggest CER molecules are
likely to cluster and form three-dimensional, but not
in-plane, microdomains in lipoprotein particles as well as
emulsions. In this study, we observed the formation of
CER-enriched domains in emulsions at 25 C. As shown
by the phase diagram constructed for CER/dim-
yristoylphosphatidylcholine [26], although the tendency for
the segregation of CER is reduced at higher temperature,
only a little amount of CER (ca. 4%) is miscible in the La
phase at 37 C. Therefore, CER molecules could form
microdomains in emulsion particles at 37 C.
Enzymatic generation of CER in SM-containing large unila-
mellar vesicles leads to extensive vesicle aggregation [27,28]. In
the present study, we demonstrated the SMase-induced aggre-
gation and fusion of emulsion particles by DLS measurement
and confocal microscopy (Figs. 1 and 5). The CER-enriched
domains may act as non-polar spots at the particle surface
and lead to particle aggregation through hydrophobic associa-
tions between the domains in diﬀerent particles [7,29,30]. It has
been shown that apoE protects against the aggregation of
LDL induced by phospholipase C and vortexing [31]. Our re-
sults showed that apoE associated with emulsion surface pre-
vented the SMase-induced aggregation and fusion of the
particles (Fig. 1), and that a large amount of apoE bound to
TO-PC/CER emulsions compared to TO-PC or TO-PC/SM
emulsions (Fig. 2). We hypothesize that apoE preferentially
binds to CER-enriched domains exposed on emulsion surface,
and thus inhibits the hydrophobic interaction between the par-
ticles followed by aggregation or fusion.
ApoE has been shown to enhance the J774 macrophage up-
take of TO-PC/CER emulsions more eﬀectively than TO-PC/
SM emulsions [12]. We have previously shown that the degree
of particle aggregation induced by SMase is negatively corre-
lated with HSPG and LRP-mediated uptake, suggesting the
large aggregated particles are limited to enter clathrin-coated
pits, and thus the association with LRP is inhibited [12]. The
size of aggregated lipoproteins may be a determinant of endo-
cytic routes. Large aggregates are expected to be restricted to
phagocytosis or patocytosis, while small aggregated lipopro-
teins may not be able to trigger the signaling required for
phagocytosis and patocytosis [32]. It is suggested that apoE en-
hances the HSPG and LRP-mediated uptake of lipoproteins
modiﬁed by SMase, not only due to the increased binding of
apoE to CER-containing lipoproteins but also to the inhibi-
tion of particle aggregation.
The apoE knockout mouse is known to develop extensive
atherosclerosis. Although the atherosclerotic lesions of thesemice contain large numbers of foam cells, plasma lipopro-
teins from the mice cause only modest cholesteryl ester accu-
mulation in macrophages [33,34]. Lipoproteins isolated from
the lesions of apoE knockout mice are aggregated and en-
riched in CER [5,35]. The lesions of apoE knockout mice
contain abundant SMase [36]. ApoE knockout lipoproteins
are susceptible to the action of SMase, because they have
a high SM/PC ratio [3,5]. Thus, SMase may play an impor-
tant role in the apoE knockout mouse. It has been shown
that macrophage-targeted expression of apoE, or transplan-
tation of apoE-expressing bone marrow, reduces early lesion
size in apoE knockout mice [37,38]. We propose that, in
apoE deﬁciency, SMase-modiﬁed lipoproteins are likely to
become large aggregates accumulated within the arterial
wall, and to be slowly internalized by macrophages. This
may represent one mechanism for the initiation of athero-
sclerosis. Therefore, the macrophage-produced apoE is sug-
gested to exert an atheroprotective eﬀect by preventing the
SMase-induced aggregation of lipoproteins.
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